logo
Laurus Labs Ltd.
03 Dec 2016, 12:00AM
861.20
1.40%
Angel Broking
Laurus Labs is a Hyderabad based company engaged in manufacturing of Active Pharma Ingredients (API). Company derives 80% of its revenues from exports while rest comes from the domestic markets. Its client base features companies like Cipla, Natco, Mylan, etc. API is its largest segment which contributes 92% of the revenues while rest 8% comes from its Synthesis and Ingredients business. Investment rationale 1) Company operates its API business model with a niche focus on select therapeutic segments. This makes it a specialist API manufacturer in a few therapeutic segments. 2) Laurus intends to enter in the US market with its...
Number of FII/FPI investors increased from 259 to 293 in Jun 2025 qtr.
More from Laurus Labs Ltd.
Recommended